Found: 6
Select item for more details and to access through your institution.
A decreasing CD4/CD8 ratio over time and lower CSF-penetrating antiretroviral regimens are associated with a higher risk of neurocognitive deterioration, independently of viral replication.
- Published in:
- Journal of NeuroVirology, 2017, v. 23, n. 2, p. 216, doi. 10.1007/s13365-016-0490-z
- By:
- Publication type:
- Article
A prospective observational post-marketing study of natalizumab-treated multiple sclerosis patients: clinical, radiological and biological features and adverse events. The BIONAT cohort.
- Published in:
- European Journal of Neurology, 2014, v. 21, n. 1, p. 40, doi. 10.1111/ene.12204
- By:
- Publication type:
- Article
P01.034 Prospective evaluation of alternative therapies in glioma patients in France.
- Published in:
- Neuro-Oncology, 2018, v. 20, p. iii236, doi. 10.1093/neuonc/noy139.076
- By:
- Publication type:
- Article
Autoimmune disorders and quadrivalent human papillomavirus vaccination of young female subjects.
- Published in:
- Journal of Internal Medicine, 2014, v. 275, n. 4, p. 398, doi. 10.1111/joim.12155
- By:
- Publication type:
- Article
Virologically suppressed patients with asymptomatic and symptomatic HIV-associated neurocognitive disorders do not display the same pattern of immune activation.
- Published in:
- HIV Medicine, 2015, v. 16, n. 7, p. 431, doi. 10.1111/hiv.12246
- By:
- Publication type:
- Article
Impact of methodological choices in comparative effectiveness studies: application in natalizumab versus fingolimod comparison among patients with multiple sclerosis.
- Published in:
- 2022
- By:
- Publication type:
- journal article